Limited Competition: Rare Diseases Clinical Research Network (RDCRN) Project Supplements for Clinical Trials to Repurpose Drugs in Collaboration with E-Rare Awardees (Admin Supp)

Funding Opportunity PA-16-183 from the NIH Guide for Grants and Contracts. This funding opportunity is intended to provide support through an administrative supplement to existing Rare Diseases Clinical Research Network (RDCRN) awardees whose projects encompass the implementation of clinical trials. Through this supplement, NCATS intends to provide support for phase 1 and/or 2 clinical trial sites that will test the potential use of an existing molecule for the treatment of a rare disease as part of a multi-site international E-Rare-3 trial.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding